216 related articles for article (PubMed ID: 34453843)
1. Potency Ranking of Per- and Polyfluoroalkyl Substances Using High-Throughput Transcriptomic Analysis of Human Liver Spheroids.
Reardon AJF; Rowan-Carroll A; Ferguson SS; Leingartner K; Gagne R; Kuo B; Williams A; Lorusso L; Bourdon-Lacombe JA; Carrier R; Moffat I; Yauk CL; Atlas E
Toxicol Sci; 2021 Oct; 184(1):154-169. PubMed ID: 34453843
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization.
Rowan-Carroll A; Reardon A; Leingartner K; Gagné R; Williams A; Meier MJ; Kuo B; Bourdon-Lacombe J; Moffat I; Carrier R; Nong A; Lorusso L; Ferguson SS; Atlas E; Yauk C
Toxicol Sci; 2021 May; 181(2):199-214. PubMed ID: 33772556
[TBL] [Abstract][Full Text] [Related]
3. Per- and polyfluoroalkyl substances (PFAS) in mixtures show additive effects on transcriptomic points of departure in human liver spheroids.
Addicks GC; Rowan-Carroll A; Reardon AJF; Leingartner K; Williams A; Meier MJ; Moffat I; Carrier R; Lorusso L; Wetmore BA; Yauk CL; Atlas E
Toxicol Sci; 2023 Jun; 194(1):38-52. PubMed ID: 37195416
[TBL] [Abstract][Full Text] [Related]
4. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects and bioconcentration of per- and polyfluoroalkyl substances (PFASs) in zebrafish (Danio rerio) embryos.
Menger F; Pohl J; Ahrens L; Carlsson G; Örn S
Chemosphere; 2020 Apr; 245():125573. PubMed ID: 31877453
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional effects of binary combinations of PFAS in FaO cells.
Bjork JA; Dawson DA; Krogstad JO; Wallace KB
Toxicology; 2021 Dec; 464():152997. PubMed ID: 34695511
[TBL] [Abstract][Full Text] [Related]
7. Patterns in Serum Toxicokinetics in Peromyscus Exposed to Per- and Polyfluoroalkyl Substances.
Narizzano AM; Bohannon ME; East AG; McDonough C; Choyke S; Higgins CP; Quinn MJ
Environ Toxicol Chem; 2021 Oct; 40(10):2886-2898. PubMed ID: 34236102
[TBL] [Abstract][Full Text] [Related]
8. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
[TBL] [Abstract][Full Text] [Related]
9. Per- and polyfluoroalkyl substances (PFAS) in Canadian municipal wastewater and biosolids: Recent patterns and time trends 2009 to 2021.
Gewurtz SB; Auyeung AS; De Silva AO; Teslic S; Smyth SA
Sci Total Environ; 2024 Feb; 912():168638. PubMed ID: 37984658
[TBL] [Abstract][Full Text] [Related]
10. Fate and effects of poly- and perfluoroalkyl substances in the aquatic environment: a review.
Ahrens L; Bundschuh M
Environ Toxicol Chem; 2014 Sep; 33(9):1921-9. PubMed ID: 24924660
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
Ojo AF; Xia Q; Peng C; Ng JC
Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
[TBL] [Abstract][Full Text] [Related]
12. Application of a Framework for Grouping and Mixtures Toxicity Assessment of PFAS: A Closer Examination of Dose-Additivity Approaches.
Goodrum PE; Anderson JK; Luz AL; Ansell GK
Toxicol Sci; 2021 Jan; 179(2):262-278. PubMed ID: 32735321
[TBL] [Abstract][Full Text] [Related]
13. Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Environ Pollut; 2020 Aug; 263(Pt B):114182. PubMed ID: 32247900
[TBL] [Abstract][Full Text] [Related]
14. Risk Assessment of Per- and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach.
Bil W; Zeilmaker M; Fragki S; Lijzen J; Verbruggen E; Bokkers B
Environ Toxicol Chem; 2021 Mar; 40(3):859-870. PubMed ID: 32729940
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends and sediment-water partitioning of per- and polyfluoroalkyl substances (PFAS) in lake sediment.
Mussabek D; Ahrens L; Persson KM; Berndtsson R
Chemosphere; 2019 Jul; 227():624-629. PubMed ID: 31009869
[TBL] [Abstract][Full Text] [Related]
16. Single PFAS and PFAS mixtures affect nuclear receptor- and oxidative stress-related pathways in precision-cut liver slices of Atlantic cod (Gadus morhua).
Dale K; Yadetie F; Horvli T; Zhang X; Frøysa HG; Karlsen OA; Goksøyr A
Sci Total Environ; 2022 Mar; 814():152732. PubMed ID: 34974025
[TBL] [Abstract][Full Text] [Related]
17. Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations.
Qin W; Henneberger L; Huchthausen J; König M; Escher BI
Environ Int; 2023 Mar; 173():107857. PubMed ID: 36881956
[TBL] [Abstract][Full Text] [Related]
18. Integrating high-throughput phenotypic profiling and transcriptomic analyses to predict the hepatosteatosis effects induced by per- and polyfluoroalkyl substances.
Luo YS; Ying RY; Chen XT; Yeh YJ; Wei CC; Chan CC
J Hazard Mater; 2024 May; 469():133891. PubMed ID: 38457971
[TBL] [Abstract][Full Text] [Related]
19. The fate of per- and polyfluoroalkyl substances within a melting snowpack of a boreal forest.
Codling G; Halsall C; Ahrens L; Del Vento S; Wiberg K; Bergknut M; Laudon H; Ebinghaus R
Environ Pollut; 2014 Aug; 191():190-8. PubMed ID: 24852410
[TBL] [Abstract][Full Text] [Related]
20. Commentary: cumulative risk assessment of perfluoroalkyl carboxylic acids and perfluoralkyl sulfonic acids: what is the scientific support for deriving tolerable exposures by assembling 27 PFAS into 1 common assessment group?
Colnot T; Dekant W
Arch Toxicol; 2022 Nov; 96(11):3127-3139. PubMed ID: 35976416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
